Soleno Therapeutics (SLNO) has a market capitalization of $3.5B, based on 59.76M shares at a price of $57.94 (down 2.9% yesterday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2025 | $57.98 | 5,087,330 | 59,757,192 | $3,464,721,992.16 |
September 2025 | $67.60 | 51,111,997 | 50,483,300 | $3,412,671,080.00 |
August 2025 | $67.67 | 33,665,865 | 50,483,300 | $3,416,204,911.00 |
July 2025 | $86.47 | 30,172,474 | 50,483,300 | $4,365,290,951.00 |
June 2025 | $83.78 | 21,319,652 | 50,483,300 | $4,229,490,874.00 |
May 2025 | $73.35 | 15,573,333 | 50,483,300 | $3,702,950,055.00 |
April 2025 | $74.86 | 28,797,485 | 50,483,300 | $3,779,179,838.00 |
March 2025 | $71.45 | 40,008,919 | 46,179,000 | $3,299,489,550.00 |
February 2025 | $48.82 | 8,073,086 | 46,179,000 | $2,254,458,780.00 |
January 2025 | $50.23 | 8,847,423 | 46,179,000 | $2,319,571,170.00 |
December 2024 | $44.95 | 14,164,912 | 43,925,000 | $1,974,428,750.00 |
November 2024 | $52.71 | 12,371,468 | 43,925,000 | $2,315,286,750.00 |
October 2024 | $55.06 | 17,620,173 | 43,925,000 | $2,418,510,500.00 |
September 2024 | $50.49 | 9,557,559 | 41,879,000 | $2,114,470,710.00 |
August 2024 | $48.95 | 12,924,738 | 41,879,000 | $2,049,977,050.00 |
July 2024 | $48.23 | 8,050,895 | 41,879,000 | $2,019,824,170.00 |
June 2024 | $40.80 | 12,169,707 | 38,631,600 | $1,576,169,280.00 |
May 2024 | $42.08 | 9,468,159 | 38,631,600 | $1,625,617,728.00 |
April 2024 | $44.66 | 9,788,790 | 38,631,600 | $1,725,287,256.00 |
March 2024 | $42.80 | 8,881,400 | 36,208,400 | $1,549,719,520.00 |
February 2024 | $48.32 | 4,782,037 | 36,208,400 | $1,749,589,888.00 |
January 2024 | $46.35 | 5,086,262 | 36,208,400 | $1,678,259,340.00 |
December 2023 | $40.25 | 9,440,800 | 34,441,700 | $1,386,278,425.00 |
November 2023 | $29.76 | 5,095,539 | 34,441,700 | $1,024,984,992.00 |
October 2023 | $23.85 | 8,025,654 | 34,441,700 | $821,434,545.00 |
